LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

Bibliographic Details
Title: LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials
Authors: Peter Cornelisse, Sandra V Navarra, Osamu Togo, Ouali Berkani, Clélia Cahuzac, Yoshinari Yokoyama
Source: Lupus Science and Medicine, Vol 10, Iss Suppl 1 (2023)
Publisher Information: BMJ Publishing Group, 2023.
Publication Year: 2023
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: Immunologic diseases. Allergy, RC581-607
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2053-8790
Relation: https://doaj.org/toc/2053-8790
DOI: 10.1136/lupus-2023-KCR.133
Access URL: https://doaj.org/article/da6707ea4ed64d78bd080a709a8460d8
Accession Number: edsdoj.6707ea4ed64d78bd080a709a8460d8
Database: Directory of Open Access Journals
More Details
ISSN:20538790
DOI:10.1136/lupus-2023-KCR.133
Published in:Lupus Science and Medicine
Language:English